Trial Profile
A Follow-up Study to Evaluate the Safety for the Patients With ALLO-ASC-DFU Treatment in Phase 1 Clinical Trial of ALLO-ASC-BI-101
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jan 2018
Price :
$35
*
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Burns
- Focus Adverse reactions
- Sponsors Anterogen
- 08 Jan 2018 Status changed from active, no longer recruiting to completed.
- 15 Jun 2017 New trial record